Fletcher Aaron G.L. (CIK 0001789490)

Latest company ownership

INAB - IN8BIO, INC.
Role: Director
Shares held
9,430,816
Last filed at
May 7, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q3 2025Q4
Shares held
6,000,000
Last filed at
Jun 11, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4
LTRN - Lantern Pharma Inc.
Role: 10% Owner
Shares held
615,596
Last filed at
May 28, 2024
Confidence Score
47.6
2025Q4
Confidence Score History
2022Q3 2025Q4
AZTR - Azitra, Inc.
Role: 10% Owner
Shares held
162,020
Last filed at
Jun 23, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q2 2025Q4
Shares held
131,248
Last filed at
Aug 20, 2024
Confidence Score
51.2
2025Q4
Confidence Score History
2024Q3 2025Q4
CUE - Cue Biopharma, Inc.
Role: Director
Shares held
10,000
Last filed at
Jan 5, 2023
Confidence Score
50.0
2025Q4
Confidence Score History
2020Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jun 27, 2025 Jun 30, 2025 ACTUATE THERAPEUTICS, INC. Director Buy 75.0 +71,428 0.71% ✗ $500K
Jun 13, 2025 Jun 13, 2025 Lantern Pharma Inc. 10% Owner Sell 22.5 -40,000 -3.58% ✗ $123.6K
Jun 10, 2025 Jun 13, 2025 Lantern Pharma Inc. 10% Owner Sell 22.5 -61,613 -5.23% ✗ $208.3K
May 27, 2025 May 29, 2025 Lantern Pharma Inc. 10% Owner Sell 22.5 -56,237 -4.56% ✗ $168.4K
Aug 14, 2024 Aug 20, 2024 ACTUATE THERAPEUTICS, INC. Director Sell 22.5 -24,999 -1.74% ✗ $200K
Aug 14, 2024 Aug 14, 2024 ACTUATE THERAPEUTICS, INC. Director Buy 100.0 +475,001 20.46% ✗ $3.8M
May 23, 2024 May 28, 2024 Lantern Pharma Inc. 10% Owner Sell 22.5 -30,000 -2.37% ✗ $189.1K
Feb 27, 2024 Feb 29, 2024 Lantern Pharma Inc. 10% Owner Sell 20.0 -144,000 -10.23% ✗ $676.3K
Jan 17, 2024 Jan 19, 2024 Lantern Pharma Inc. 10% Owner Sell 22.5 -58,889 -4.02% ✗ $247.3K
Nov 29, 2023 Dec 1, 2023 Lantern Pharma Inc. 10% Owner Sell 20.0 -145,348 -9.48% ✗ $500K
Jun 21, 2023 Jun 23, 2023 Azitra, Inc. 10% Owner Buy 100.0 +1,628,173 195.85% ✗ $3M
Dec 12, 2022 Dec 13, 2022 IN8BIO, INC. Director Buy 82.5 +75,001 1.55% ✗ $185.9K
Nov 28, 2022 Nov 29, 2022 COGNITION THERAPEUTICS INC Director Buy 61.3 +16,064 0.29% ✗ $42.6K
Nov 16, 2022 Nov 17, 2022 COGNITION THERAPEUTICS INC Director Buy 82.5 +71,000 1.31% ✗ $99.4K
Nov 15, 2022 Nov 16, 2022 COGNITION THERAPEUTICS INC Director Buy 100.0 +1,500,000 38.34% ✗ $1.8M
Nov 8, 2022 Nov 9, 2022 Lantern Pharma Inc. 10% Owner Sell 17.5 -350,000 -18.59% ✗ $1.5M
Sep 28, 2022 Sep 29, 2022 IN8BIO, INC. Director Buy 72.5 +25,000 0.52% ✗ $50.5K
Sep 2, 2022 Sep 7, 2022 Lantern Pharma Inc. 10% Owner Sell 43.8 -6,445 -0.34% ✗ $33.5K
Aug 26, 2022 Aug 30, 2022 IN8BIO, INC. Director Buy 72.5 +51,214 0.54% ✗ $103.3K
Aug 17, 2022 Aug 18, 2022 IN8BIO, INC. Director Buy 82.5 +50,000 1.06% ✗ $96.5K
Aug 16, 2022 Aug 17, 2022 IN8BIO, INC. Director Buy 100.0 +1,773,684 69.31% ✗ $3.4M
May 23, 2022 May 25, 2022 Cue Biopharma, Inc. Director Buy 97.5 +205,000 22.56% ✗ $711.7K
Mar 31, 2022 Apr 4, 2022 Cue Biopharma, Inc. Director Buy 100.0 +735,000 422.74% ✗ $3.5M
Oct 13, 2021 Oct 15, 2021 COGNITION THERAPEUTICS INC Director Buy 100.0 +189,909 15.31% ✗ $2.3M
Nov 24, 2020 Nov 25, 2020 Cue Biopharma, Inc. Director Buy 87.5 +6,548 3.91% ✗ $82.8K
Jun 24, 2020 Jun 25, 2020 Cue Biopharma, Inc. Director Buy 87.5 +7,500 4.69% ✗ $186.6K